Citations 1
PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA
Soussain, C., Grommes, C., Ward, R., Peterson, C., Cravets, M., Mathias, A., Sosa, J., Kirby, B., Ding, Zhenduo, Yusuf, Issa Radwan , Rose, M., Steinberg, M., Tun, H., Soussain, Carole , Grommes, Christian , Cravets, Matt
HemaSphere | June 25, 2022 | Volume: 6 | Issue: No issue available | Pages: 1967-1968
